 JPMorgan Chase Co. grew its stake in shares of LogicBio Therapeutics Inc NASDAQ:LOGC by 2,690.7 during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 407,921 shares of the companys stock after purchasing an additional 393,304 shares during the period. JPMorgan Chase Co. owned approximately ... 